In the news today, we’re hearing about a UK research study that has suggested the hallmark Alzheimer’s protein, amyloid, could have been passed between people in historic treatments with human-derived growth hormone in the 60s and 70s.
If we don’t understand in detail the level and depth of public awareness of dementia, we won’t be able to communicate effectively with people or help to educate and address misconceptions.
A new analysis clinical trials has concluded that taking B vitamins doesn’t slow decline in memory and thinking and is unlikely to prevent Alzheimer’s disease.
It may not be tomorrow, but I look forward to the day soon when we can comment on a real breakthrough treatment – one that can truly make a difference.
Can what we eat affect our chances of developing dementia? Alison Cranage looks at the evidence.
Does Ginkgo biloba relieve the symptoms of Alzheimer’s? We look at the gathered the evidence of 36 clinical trials from around the world and their results.